No title available.Ruan Y., Wei C.L., Ling A.E., Vega V.B., Thoreau H., Se Thoe S.Y., Chia J.-M., Ng P., Chiu K.P.[...], Liu E.T.Cited forERRATUM OF PUBMED:12781537SourceUniProtKB reviewed (Swiss-Prot)Lancet 361:1832-1832 (2003)Cited in6
Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N- terminus and trimerization of the ectodomain.Xiao X., Feng Y., Chakraborti S., Dimitrov D.S.View abstractCited forHOMOTRIMERIZATIONSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCBiochem. Biophys. Res. Commun. 322:93-99 (2004)Cited in1
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.Sainz B. Jr., Rausch J.M., Gallaher W.R., Garry R.F., Wimley W.C.View abstractCited forCHARACTERIZATION OF FUSION PEPTIDESourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCJ. Virol. 79:7195-7206 (2005)Cited in1
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., Bates P.View abstractCited forPROTEOLYSIS BY HUMAN CTSLSourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCProc. Natl. Acad. Sci. U.S.A. 102:11876-11881 (2005)Cited in2
The SARS-CoV fusion peptide forms an extended bipartite fusion platform that perturbs membrane order in a calcium-dependent manner.Lai A.L., Millet J.K., Daniel S., Freed J.H., Whittaker G.R.View abstractCited forCHARACTERIZATION OF FUSION PEPTIDESourceUniProtKB reviewed (Swiss-Prot)PubMedEurope PMCJ. Mol. Biol. 429:3875-3892 (2017)Cited in1